期刊文献+

氨基糖苷类药物在重度感染患者中的应用 被引量:2

The application of aminoglycoside antibiotics in severe infections
下载PDF
导出
摘要 氨基糖苷类药物主要用于敏感需氧革兰阴性杆菌所致感染治疗。因耳毒性和肾毒性等不良反应,使其在临床上、尤其是在重度感染中的应用受到较大限制。但氨基糖苷类药物属静止期杀菌剂,对常见革兰阴性杆菌如铜绿假单胞菌、肺炎克雷伯菌和大肠埃希菌等的抗生素后效应较长、杀菌作用完全,在治疗需氧革兰阴性杆菌和阳性菌所致重度感染治疗中有着不可替代的作用。 Aminoglycoside antibiotics are a class of antibacterial agents having the structure of amino sugar and aminocyclitol,which is effective against the infections caused by the sensitive aerobic Gram-negative bacilli.Because of its side effects of ototoxicity and nephrotoxicity and so on,it is restricted in the clinical usage especially in severe infections.But the aminoglycoside antibiotics are a quiescent bactericide.It has longer post antibiotic effect on the common Gram-negative bacilli such as Pseudomonas aeruginosa,Klebsiella pneumonia,Escherichia coli and complete bactericidal action.So aminoglycoside antibiotics play an irreplaceable role in treatment of severe infections caused by aerobic Gram-negative bacilli and positive bacteria.
作者 李峰 王春华
出处 《上海医药》 CAS 2012年第13期8-12,共5页 Shanghai Medical & Pharmaceutical Journal
关键词 氨基糖苷类药物 重度感染 治疗 aminoglycoside antibiotics severe infection treatment
  • 相关文献

参考文献13

  • 1段宁,崔德健.氨基糖苷类抗生素进展与临床应用——抗感染合理用药专家圆桌会议纪要[J].中国医院用药评价与分析,2008,8(2):81-84. 被引量:16
  • 2D. E. Ghannam,G. H. Rodriguez,I. I. Raad,A. Safdar.Inhaled aminoglycosides in cancer patients with ventilator-associated Gram-negative bacterial pneumonia: safety and feasibility in the era of escalating drug resistance[J].European Journal of Clinical Microbiology & Infectious Diseases.2009(3)
  • 3Matitiahu Berkovitch,Michael Goldman,Rela Silverman,Zehava Chen-Levi,Revital Greenberg,Ora Marcus,Eliezer Lahat.Therapeutic drug monitoring of once daily gentamicin in serum and saliva of children[J].European Journal of Pediatrics.2000(9)
  • 4Kashuba AD,Nafziger AN,Drusano GL,et al.Optimizing aminoglycoside therapy for nosocomial pneumonia caused by Gram-negative bacteria[].Antimicrobial Agents and Chemotherapy.1999
  • 5Kumar A,Zarychanski R,Light B,et al.Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock:a propensity matched analysis[].Critical Care Medicine.2010
  • 6Paul M,Soares-Weiser K,Leibovici L.beta-lactam monotherapy versus beta-lactam-aminoglycoside combination therapy for fever with neutropenia:systematic review and meta-analysis[].British Medical Journal.2003
  • 7Bailey JA,Virgo KS,Dipiron JT,et al.Aminoglycosides for intra-abdominal infection:equal to the challenge?[].Surgical Infections.2002
  • 8Michael B,John PAI,Joseph CC et al.Single or multiple daily doses of aminoglycosidesa meta - analysis[].British Medical Journal.1996
  • 9Serena Bernacchi,Séverine Freisz,Clarisse Maechling ,et al.Aminoglycoside binding to the HIV-1 RNA dimerization initiation site: thermodynamics and effect on the kissing-loop to duplex conversion.[].Nucleic Acids Research.2007
  • 10Goscinski G,LundholmM,Odenholt I,et al.Variationinthe propensi-tyto release endotoxin after cefuroxime exposure in different gram-nega-tive bacteria:uniformand dose-dependent reduction bythe additionof to-bramycin[].Scandinavian Journal of Infectious Diseases.2003

二级参考文献11

  • 1Centers for Disease Control and Prevention ( CDC ). Staphylococcus aureus resistant to vancomycin United States, 2002 [J]. MMWR Morb Mortal Wkly Rep, 2002, 51 (26) :565.
  • 2Vanhoof R, Nyssen HJ, Van Bossuyt E,et al. Aminoglycoside resistance in Gram-negative blood isolates from various hospitals in Belgium and the Grand Duchy of Luxembourg. Aminoglycoside Resistance Study Group [ J ] . J Antimicrob Chemother, 1999,44 (4) : 483.
  • 3Bell J, Tumidge J. SENTRY Antimicrobial Surveillance Program Asia-Pacific region and South Africa [J]. Commun Dis Intell,2003,27 (Suppl) : S61.
  • 4El Mouedden M, Laurent G, Mingeot-Leclercq MP, et al. Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides [ J] . Antimicrob Agents Chemother, 2000,44(3) :665.
  • 5ougier F, Claude D, Maurin M, et al. Aminoglycoside nephrotoxicity: modeling, simulation, and control [ J ]. Antimicrob Agents Chemother, 2003 ;47(3) : 1 010.
  • 6Craig WA. Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man [J]. J Antimicrob Chemother, 1993, 31 (Suppl D) : 149.
  • 7Tod M, Padoin C, Petitjean O. Clinical pharmacokinetics and pharmacodynamics of isepamicin [ J ]. Clin Pharmacokinet, 2000,38(3) :205.
  • 8Mingeot-Leclercq MP, Tulkens PM. Aminoglycosides: nephrotoxicity [ J ]. Antimicrob Agents Chemother, 1999, 43 (5) : 1003.
  • 9李胜利,张婴元,周乐,汪复.30种抗菌药物对临床分离葡萄球菌体外抗菌作用的研究[J].中国抗生素杂志,1997,22(6):447-450. 被引量:15
  • 10杨镜明,刘瑛.异帕米星的体外抗菌活性及临床应用[J].中国新药与临床杂志,2002,21(1):33-35. 被引量:15

共引文献15

同被引文献18

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部